To investigate the potential mechanisms of SGLT2 inhibition-induced senolysis, we next performed a metabolomic analysis in the HFD-induced obesity model after treatment with canagliflozin. Here, SLC5A2 is linked to obesity due to melanocortin 4 receptor deficiency.